Pocket Guide to Chronic Lymphocytic Leukemia

_Introduction to chronic lymphocytic leukemia.- Clinical features and classification.- Diagnosis, staging and prognosis.- Treatment options by disease stage.- Specific treatment options for chronic lymphocytic leukemia.- Emerging therapies and the future outlook for chronic lymphocytic leukemia.

Susan M. O'Brien is Ashbel Smith Professor in the Department of Leukemia and Clinical Consultant and Special Assistant to the Physician-in-Chief at The University of Texas MD Anderson Cancer Center in Houston, Texas. Dr O'Brien receiver her MD degree from the University of Medicine and Dentistry of New Jersey in Newark in 1980. She went on to complete a residency in internal medicine at the University of Medicine and Dentistry of New Jersey in 1983. She then served there as an Instructor in Medicine from 1983 to 1984 before moving to California, where she served as an Instructor in the San Fernando Valley Program in the University of California, Los Angeles School of Medicine and an Internist in the University of Southern California Student Health Service. In 1985, Dr O'Brien came to MD Anderson, where she completed a fellowship in 1987. She then joined the MD Anderson faculty as a Faculty Associate. She went on to be promoted to Instructor in 1988, Assistant Professor in 1989, and Associate Professor in 1995. She was named Clinical Consultant and Special Assistant to the Physician-in-Chief in 1997 and promoted to her current position of Professor in 1999. Dr O'Brien has served on a wide array of committees and groups at MD Anderson. Specifically, she has been the Chair for the Institutional Review Board since 2007 and a member of the board since 1997. She also has been a member of the Standing Committee for Clinical Affairs since 1997. During her time at MD Anderson, Dr O'Brien has been the principal investigator or a co-principal investigator for 5 funded research projects and the primary investigator for more than 20 funded protocols. In addition, she has served on the Translational Research Study Section for the Leukemia and Lymphoma Society since 2001. Dr O'Brien has been honored multiple times for her clinical efforts. In particular, she received the Fourth Annual Melvin L. Samuels Award for Excellence in Patient Care; made the Best Doctors in America list in